What is MicroAlgo, Inc.'s earnings per share (EPS)?

MicroAlgo, Inc. (MLGO) reported diluted earnings per share of $2.12 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

MicroAlgo, Inc. (MLGO) Financials

MLGO

FY2025 annual

Revenue $60.0M -20.3% YoY

Net Income $18.1M +149.0% YoY

EPS (Diluted) $2.12 YoY not available

Free Cash Flow $2.5M -39.1% YoY

Market Cap $30.4M as of Oct 15, 2026

Price / Sales 0.5x on $60.0M revenue, FY2025

Price / Earnings 1.7x on $18.1M net income, FY2025

Price / Book 0.1x on $330.3M equity, Q4 FY2025

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 15, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period FY2025, ended Dec 31, 2025 Reported Apr 1, 2026 Currency USD FYE December

Newest figures come from the 10-K for FY2025, filed Apr 1, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the MLGO SEC filings page.

MicroAlgo, Inc. (MLGO) reported $60.0M in revenue for fiscal year 2025, down 20.3% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI MLGO FY2025 2026-10-03

Reported profit is not translating into cash: FY2025 revenue fell, while financing activity reshaped a much larger balance sheet.

Earnings quality weakened because FY2025 net income reached $18.1M while operating cash flow was only $2.5M; the gap means the reported bottom line was not primarily converted into cash from operations. This contrasts with FY2024, when net income of $7.3M was broadly matched by operating cash flow of $4.1M.

Core operating momentum remains limited: revenue declined 20.3% in FY2025, and gross margin narrowed from 28.4% to 25.8%. Yet operating margin improved from 3.7% to 5.3%, indicating lower operating expenses partly offset the weaker gross-profit base rather than scale-driven expansion.

The balance sheet expanded mainly through financing flows: assets rose from $176.3M to $350.3M, while financing cash flow supplied $153.9M and investing cash flow used $121.8M. Reported debt-to-equity also fell from 0.2x to 0.0x, so the enlarged structure is characterized more by equity than leverage.

Financial Health Signals

Financial Health Score 43/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of MicroAlgo, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

MicroAlgo, Inc. has an operating margin of 5.3%, meaning the company retains $5 of operating profit per $100 of revenue. This below-average margin results in a low score of 20/100, suggesting thin profitability after operating expenses. This is up from 3.7% the prior year.

Growth

MicroAlgo, Inc.'s revenue declined 20.3% year-over-year, from $75.3M to $60.0M. This contraction results in a growth score of 6/100.

Leverage

MicroAlgo, Inc. carries a low D/E ratio of 0.05, meaning only $0.05 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 84/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

100

With a current ratio of 22.53, MicroAlgo, Inc. holds $22.53 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 100/100.

Cash Flow

MicroAlgo, Inc. has a free cash flow margin of 4.1%, earning a moderate score of 33/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns

MicroAlgo, Inc. generates a 5.5% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 15/100. This is up from 5.0% the prior year.

Altman Z-Score Grey Zone

2.56

MicroAlgo, Inc. scores 2.56, placing it in the grey zone between 1.81 and 2.99. This signals moderate financial risk that warrants monitoring.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial

4/7

MicroAlgo, Inc. passes 4 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 3 of 4 profitability signals pass, all 1 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Low Quality

0.14x

For every $1 of reported earnings, MicroAlgo, Inc. generates $0.14 in operating cash flow ($2.5M OCF vs $18.1M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Interest Coverage Safe

13.51x

MicroAlgo, Inc. earns $13.51 in operating income for every $1 of interest expense ($3.2M vs $236K). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.

Key Financial Metrics

Export CSV

Earnings & Revenue

None of these metrics is reported for Q4 2025.

Cash & Balance Sheet

Cash & Debt

$174.8M

YoY+21.3%

QoQ-31.0%

MicroAlgo, Inc. held $174.8M in cash as of Q4 2025; long-term debt is not reported for that period.

Free Cash Flow

Not reported for Q4 2025.

Dividends Per Share

Not reported for Q4 2025.

Shares Outstanding

Not reported for Q4 2025.

Margins & Returns

None of these metrics is reported for Q4 2025.

Capital Allocation

None of these metrics is reported for Q4 2025.

MLGO Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

MLGO quarterly income statement

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K
Revenue	$60.0M-20.3%	$75.3M-8.0%	$81.9M-6.0%	$87.1M+6.2%	$82.0M	N/A
Cost of Revenue	$44.6M-17.4%	$53.9M-5.9%	$57.3M-15.9%	$68.2M+39.4%	$48.9M	N/A
Gross Profit	$15.5M-27.6%	$21.4M-12.9%	$24.6M+29.6%	$19.0M-42.8%	$33.1M+28215.9%	-$118K
R&D Expenses	$9.0M-42.1%	$15.5M-31.7%	$22.8M+63.4%	$13.9M-16.0%	$16.6M	N/A
SG&A Expenses	$3.0M+8.6%	$2.7M-21.9%	$3.5M-31.4%	$5.1M-2.8%	$5.3M	N/A
Operating Income	$3.2M+13.7%	$2.8M+108.1%	-$34.6M-340.4%	-$7.9M-197.7%	$8.0M	N/A
EBITDA	$3.4M+13.4%	$3.0M+108.9%	-$33.6M-418.1%	-$6.5M-168.0%	$9.5M	N/A
Interest Expense	$236K-93.7%	$3.7M+581.0%	$548K+106.1%	$266K-8.9%	$292K	N/A
Income Tax	$1.0M+22.2%	$854K+341.9%	-$353K+37.5%	-$565K-765.9%	$85K	N/A
Net Income	$18.1M+149.0%	$7.3M+119.4%	-$37.6M-439.7%	-$7.0M-181.3%	$8.6M+7374.1%	-$118K
EPS (Basic)	$2.12+45.2%	$1.46+117.6%	-$8.30	N/A	N/A	N/A
EPS (Diluted)	$2.12	$0.56	-$8.30	N/A	N/A	N/A
Diluted Shares (Avg)	8M	10M	22,810+14.5%	19,930	4M	N/A

Metric	Q4'2510-K	Q2'256-K	Q4'2410-K	Q2'2410-Q	Q4'2310-K	Q2'2310-Q	Q1'2310-Q	Q4'2210-Q
Revenue	N/A	N/A	N/A	N/A	N/A	N/A	$17.8M-23.7%	N/A
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	$12.9M-28.3%	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	$5.0M-8.2%	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	$5.2M+63.2%	N/A
SG&A Expenses	N/A	N/A	N/A	N/A	N/A	N/A	$1.0M+25.7%	N/A
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A	-$1.4M-220.1%	N/A
EBITDA	N/A	N/A	N/A	N/A	N/A	N/A	-$1.3M-185.9%	N/A
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A	$4K-86.2%	N/A
Income Tax	N/A	N/A	N/A	N/A	N/A	N/A	$5K-54.3%	N/A
Net Income	N/A	N/A	N/A	N/A	N/A	N/A	-$1.3M-242.4%	N/A

Not reported in any period shown, so not listed: EPS (Basic), EPS (Diluted), Diluted Shares (Avg).

MLGO Balance Sheet

MLGO quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K
Total Assets	$350.3M+98.8%	$176.3M+204.1%	$58.0M-19.6%	$72.1M-11.7%	$81.6M+42507.6%	$192K
Current Assets	$350.1M+99.0%	$175.9M+205.2%	$57.6M+4.4%	$55.2M+2.2%	$54.0M+70652.7%	$76K
Cash & Equivalents	$174.8M+21.3%	$144.1M+221.8%	$44.8M+4.8%	$42.7M+0.1%	$42.7M+17874291.2%	$239
Short-Term Investments	$161.9M+678.1%	$20.8M+700.5%	$2.6M	$0	$0	$0
Inventory	N/A	N/A	N/A	$131K-84.2%	$824K	N/A
Accounts Receivable	$6.2M+88.0%	$3.3M+1.5%	$3.2M+24.8%	$2.6M-6.0%	$2.8M	N/A
Long-Term Investments	$14K	$0	$0	$0	$0	$0
Goodwill	N/A	N/A	N/A	$15.3M-30.5%	$21.9M	N/A
Total Liabilities	$15.6M-46.1%	$28.9M+139.8%	$12.0M+137.3%	$5.1M-77.9%	$23.0M+7680.5%	$295K
Current Liabilities	$15.5M-46.0%	$28.8M+139.0%	$12.0M+150.8%	$4.8M-78.1%	$22.0M+7340.1%	$295K
Non-Current Liabilities	$34K-64.6%	$97K	$0-100.0%	$272K-72.9%	$1.0M	$0
Total Equity	$330.3M+127.9%	$144.9M+219.4%	$45.4M-32.0%	$66.8M+14.3%	$58.4M+56437.9%	-$104K
Retained Earnings	$11.4M+344.1%	-$4.7M+57.1%	-$10.9M-156.9%	$19.1M-27.7%	$26.5M+20683.7%	-$129K

Metric	Q4'2510-K	Q2'256-K	Q4'2410-K	Q2'2410-Q	Q4'2310-K	Q2'2310-Q	Q1'2310-Q	Q4'2210-Q
Total Assets	$350.3M+98.8%	$330.8M+207.5%	$176.3M+204.1%	$107.6M+49.8%	$58.0M-19.6%	$71.8M+51.7%	$75.6M+61.6%	$72.1M-11.7%
Current Assets	$350.1M+99.0%	$330.5M+208.0%	$175.9M+205.2%	$107.3M+92.1%	$57.6M+4.4%	$55.9M+137345.0%	$58.7M+204724.4%	$55.2M+2.2%
Cash & Equivalents	$174.8M+21.3%	$253.3M+316.5%	$144.1M+221.8%	$60.8M+216.9%	$44.8M+4.8%	$19.2M+175987.3%	$21.0M+73182.4%	$42.7M+0.1%
Short-Term Investments	$161.9M+678.1%	$66.1M+1028.2%	$20.8M+700.5%	$5.9M	$2.6M	$0	$0	$0
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$131K-84.2%
Accounts Receivable	$6.2M+88.0%	$3.3M+8.5%	$3.3M+1.5%	$3.0M-42.0%	$3.2M+24.8%	$5.2M	$1.6M	$2.6M-6.0%
Long-Term Investments	$14K	$14K	$0	$0	$0	$0	$0	$0
Goodwill	N/A	N/A	N/A	N/A	N/A	$14.7M	$15.5M	$15.3M-30.5%
Total Liabilities	$15.6M-46.1%	$10.1M-66.8%	$28.9M+139.8%	$30.3M+155.0%	$12.0M+137.3%	$11.9M-76.4%	$8.7M-82.3%	$5.1M-77.9%
Current Liabilities	$15.5M-46.0%	$10.0M-66.9%	$28.8M+139.0%	$30.2M+160.1%	$12.0M+150.8%	$11.6M+682.5%	$8.4M+813.5%	$4.8M-78.1%
Non-Current Liabilities	$34K-64.6%	$54K-4.7%	$97K	$57K-77.5%	$0-100.0%	$252K-99.5%	$306K-99.4%	$272K-72.9%
Total Equity	$330.3M+127.9%	$317.6M+318.0%	$144.9M+219.4%	$76.0M+25.8%	$45.4M-32.0%	$60.4M+2105.2%	$66.7M+2807.5%	$66.8M+14.3%
Retained Earnings	$11.4M+344.1%	-$992K+88.4%	-$4.7M+57.1%	-$8.5M-159.3%	-$10.9M-156.9%	$14.4M+578.4%	$17.9M+825.9%	$19.1M-27.7%

Not reported in any period shown, so not listed: Long-Term Debt.

MLGO Cash Flow Statement

MLGO quarterly cash flow statement

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K
Operating Cash Flow	$2.5M-39.1%	$4.1M+163.6%	-$6.4M-427.9%	$2.0M-87.2%	$15.3M+19726.6%	-$78K
Depreciation & Amortization	$197K+9.9%	$179K-82.3%	$1.0M-26.2%	$1.4M-7.6%	$1.5M	N/A
Stock-Based Compensation	N/A	N/A	$16.9M	N/A	N/A	N/A
Capital Expenditures	$1K-70.9%	$4K-60.9%	$10K-93.7%	$161K+346.9%	$36K	N/A
Free Cash Flow	$2.5M-39.1%	$4.1M+163.4%	-$6.4M-457.9%	$1.8M-88.2%	$15.2M	N/A
Investing Cash Flow	-$121.8M-602.7%	-$17.3M-634.5%	-$2.4M-185.4%	$2.8M+142.6%	-$6.5M-11788752.7%	-$55
Financing Cash Flow	$153.9M+36.8%	$112.5M+941.3%	$10.8M+546.1%	-$2.4M+37.0%	-$3.8M-999.0%	-$350K

Metric	Q4'2510-K	Q2'256-K	Q4'2410-K	Q2'2410-Q	Q4'2310-K	Q2'2310-Q	Q1'2310-Q	Q4'2210-Q
Operating Cash Flow	N/A	N/A	N/A	N/A	N/A	-$3.8M-411.6%	-$2.8M-704.8%	$2.3M-85.4%
Depreciation & Amortization	N/A	N/A	N/A	N/A	N/A	N/A	$107K-68.8%	N/A
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	$11.5M+389409.9%	$54K-70.7%	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	-$15.3M-1941.2%	-$2.8M-1139.7%	N/A
Investing Cash Flow	N/A	N/A	N/A	N/A	N/A	$481K	-$257K+98.4%	$4.1M-89.6%
Financing Cash Flow	N/A	N/A	N/A	N/A	N/A	$1.8M-69.2%	-$19.6M-255.7%	-$4.2M+91.8%

Not reported in any period shown, so not listed: Stock-Based Compensation, Dividends Paid, Share Buybacks.

MLGO Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

MLGO quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K
Gross Margin	25.8%-2.6pp	28.4%-1.6pp	30.0%+8.2pp	21.8%-18.6pp	40.4%	N/A
Operating Margin	5.3%+1.6pp	3.7%+46.0pp	-42.3%-33.3pp	-9.0%-18.8pp	9.8%	N/A
Net Margin	30.2%+20.5pp	9.7%+55.6pp	-45.9%-37.9pp	-8.0%-18.4pp	10.4%	N/A
Return on Equity	5.5%+0.5pp	5.0%+87.9pp	-82.8%-72.4pp	-10.4%-25.1pp	14.7%	N/A
Return on Assets	5.2%+1.0pp	4.1%+69.0pp	-64.8%-55.2pp	-9.7%-20.2pp	10.5%+72.0pp	-61.5%
Current Ratio	22.53+16.4x	6.11+1.3x	4.79-6.7x	11.49+9.0x	2.46+2.2x	0.26
Debt-to-Equity	0.05-0.2x	0.20-0.1x	0.27+0.2x	0.08-0.3x	0.39	N/A
Asset Turnover	0.17-0.3x	0.43-1.0x	1.41+0.2x	1.21+0.2x	1.01	N/A
FCF Margin	4.1%-1.3pp	5.4%+13.3pp	-7.8%-9.9pp	2.1%-16.5pp	18.6%	N/A

Metric	Q4'2510-K	Q2'256-K	Q4'2410-K	Q2'2410-Q	Q4'2310-K	Q2'2310-Q	Q1'2310-Q	Q4'2210-Q
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	27.8%+4.7pp	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A	-7.9%-13.0pp	N/A
Net Margin	N/A	N/A	N/A	N/A	N/A	N/A	-7.1%-10.9pp	N/A
Return on Equity	N/A	N/A	N/A	N/A	N/A	N/A	-1.9%	N/A
Return on Assets	N/A	N/A	N/A	N/A	N/A	N/A	-1.7%-3.6pp	N/A
Current Ratio	22.53+16.4x	33.05+29.5x	6.11+1.3x	3.55-1.3x	4.79-6.7x	4.81+4.8x	6.98+6.9x	11.49+9.0x
Debt-to-Equity	0.05-0.2x	0.03-0.4x	0.20-0.1x	0.40+0.2x	0.27+0.2x	0.20	0.13	0.08-0.3x
Asset Turnover	N/A	N/A	N/A	N/A	N/A	N/A	0.24-0.3x	N/A
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	-15.8%-17.0pp	N/A

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
MicroAlgo, Inc. MLGO	FY2025	$60.0M	$18.1M	30.2%	$30.4M	43/100
AEye, Inc. LIDR	FY2025	$233K	-$34.0M	N/A	$39.3M	—
XBP Global Holdings, Inc. XBP	FY2024	$872.7M	-$215.2M	-24.6%	$43.2M	13/100
Katapult Holdings, Inc. KPLT	FY2025	$291.8M	$1.4M	0.5%	$417.5M	28/100
Alarum Technologies Ltd. ALAR	FY2025	$40.8M	$963K	2.4%	$10.3M	19/100
VirnetX Holding Corp VHC	FY2025	$162K	-$18.2M	N/A	$45.8M	—

Where MicroAlgo, Inc. Ranks

Frequently Asked Questions

What is MicroAlgo, Inc.'s annual revenue?

MicroAlgo, Inc. (MLGO) reported $60.0M in total revenue for fiscal year 2025. This represents a -20.3% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is MicroAlgo, Inc.'s revenue growing?

MicroAlgo, Inc. (MLGO) revenue declined by 20.3% year-over-year, from $75.3M to $60.0M in fiscal year 2025.

Is MicroAlgo, Inc. profitable?

Yes, MicroAlgo, Inc. (MLGO) reported a net income of $18.1M in fiscal year 2025, with a net profit margin of 30.2%.

What is MicroAlgo, Inc.'s EBITDA?

MicroAlgo, Inc. (MLGO) had EBITDA of $3.4M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

What is MicroAlgo, Inc.'s gross margin?

MicroAlgo, Inc. (MLGO) had a gross margin of 25.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is MicroAlgo, Inc.'s operating margin?

MicroAlgo, Inc. (MLGO) had an operating margin of 5.3% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is MicroAlgo, Inc.'s net profit margin?

MicroAlgo, Inc. (MLGO) had a net profit margin of 30.2% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is MicroAlgo, Inc.'s return on equity (ROE)?

MicroAlgo, Inc. (MLGO) has a return on equity of 5.5% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is MicroAlgo, Inc.'s free cash flow?

MicroAlgo, Inc. (MLGO) generated $2.5M in free cash flow during fiscal year 2025. This represents a -39.1% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is MicroAlgo, Inc.'s operating cash flow?

MicroAlgo, Inc. (MLGO) generated $2.5M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are MicroAlgo, Inc.'s total assets?

MicroAlgo, Inc. (MLGO) had $350.3M in total assets as of fiscal year 2025, including both current and long-term assets.

What are MicroAlgo, Inc.'s capital expenditures?

MicroAlgo, Inc. (MLGO) invested $1K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does MicroAlgo, Inc. spend on research and development?

MicroAlgo, Inc. (MLGO) invested $9.0M in research and development during fiscal year 2025.

What is MicroAlgo, Inc.'s current ratio?

MicroAlgo, Inc. (MLGO) had a current ratio of 22.53 as of fiscal year 2025, which is generally considered healthy.

What is MicroAlgo, Inc.'s debt-to-equity ratio?

MicroAlgo, Inc. (MLGO) had a debt-to-equity ratio of 0.05 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is MicroAlgo, Inc.'s return on assets (ROA)?

MicroAlgo, Inc. (MLGO) had a return on assets of 5.2% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is MicroAlgo, Inc.'s P/E ratio?

MicroAlgo, Inc. (MLGO) trades at 1.7x earnings, its market capitalization divided by net income of $18.1M net income, FY2025. The market capitalization is $30.4M as of Oct 15, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is MicroAlgo, Inc.'s price-to-sales ratio?

MicroAlgo, Inc. (MLGO) trades at 0.5x sales, its market capitalization divided by revenue of $60.0M revenue, FY2025. The market capitalization is $30.4M as of Oct 15, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is MicroAlgo, Inc.'s Altman Z-Score?

MicroAlgo, Inc. (MLGO) has an Altman Z-Score of 2.56, placing it in the Grey Zone (moderate risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is MicroAlgo, Inc.'s Piotroski F-Score?

MicroAlgo, Inc. (MLGO) has a Piotroski F-Score of 4 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are MicroAlgo, Inc.'s earnings high quality?

MicroAlgo, Inc. (MLGO) has an earnings quality ratio of 0.14x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can MicroAlgo, Inc. cover its interest payments?

MicroAlgo, Inc. (MLGO) has an interest coverage ratio of 13.51x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is MicroAlgo, Inc.?

MicroAlgo, Inc. (MLGO) scores 43 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.